Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Joseph A. Bovi MD

Joseph A. Bovi MD profile photo picture

Professor

Institution: Medical College of Wisconsin
Department: Radiation Oncology
Program: Clinical

Member of the Cancer Center

View Curriculum Vitae

Publications (32)

  • Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes. (Bovi JA, Prah MA, Retzlaff AA, Schmainda KM, Connelly JM, Rand SD, Marszalkowski CS, Mueller WM, Siker ML, Schultz CJ) Int J Radiat Oncol Biol Phys 2020 Nov 15;108(4):979-986 PMID: 32599030 SCOPUS ID: 2-s2.0-85089292279 07/01/2020    
  • ACR-ASTRO Practice Parameter for Communication: Radiation Oncology. (Schechter NR, Brown DW, Bovi JA, Dominello MM, Liu AK, Mattes MD, Michalski JM, Shih HA, Strom E, Wilkinson JB, Rosenthal SA, Hartford A) Am J Clin Oncol 2020 08;43(8):553-558 PMID: 32520791 SCOPUS ID: 2-s2.0-85089126288 06/11/2020    
  • Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424. (Fisher BJ, Pugh SL, Macdonald DR, Chakravatri A, Lesser GJ, Fox S, Rogers CL, Werner-Wasik M, Doyle T, Bahary JP, Fiveash JB, Bovi JA, Howard SP, Michael Yu HH, D'Souza D, Laack NN, Barani IJ, Kwok Y, Wahl DR, Strasser JF, Won M, Mehta MP) Int J Radiat Oncol Biol Phys 2020 Jul 15;107(4):720-725 PMID: 32251755 PMCID: PMC7456814 SCOPUS ID: 2-s2.0-85084750157 04/07/2020       1 Citation
  • Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. (Brown PD, Gondi V, Pugh S, Tome WA, Wefel JS, Armstrong TS, Bovi JA, Robinson C, Konski A, Khuntia D, Grosshans D, Benzinger TLS, Bruner D, Gilbert MR, Roberge D, Kundapur V, Devisetty K, Shah S, Usuki K, Anderson BM, Stea B, Yoon H, Li J, Laack NN, Kruser TJ, Chmura SJ, Shi W, Deshmukh S, Mehta MP, Kachnic LA, for NRG Oncology) J Clin Oncol 2020 Apr 01;38(10):1019-1029 PMID: 32058845 PMCID: PMC7106984 SCOPUS ID: 2-s2.0-85082562099 02/15/2020       27 Citations
  • Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933. (Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA) Adv Radiat Oncol 2019 Oct-Dec;4(4):579-586 PMID: 31673651 PMCID: PMC6817553 11/02/2019    
  • Unease With Uncertainty (Bovi J) International Journal of Radiation Oncology Biology Physics 1 October 2019;105(2):244-245 SCOPUS ID: 2-s2.0-85071371866 10/01/2019    
  • Unease With Uncertainty. (Bovi J) Int J Radiat Oncol Biol Phys 2019 10 01;105(2):244-245 PMID: 31492381 SCOPUS ID: 2-s2.0-85071371866 09/08/2019    
  • NRG brain tumor specialists consensus guidelines for glioblastoma contouring. (Kruser TJ, Bosch WR, Badiyan SN, Bovi JA, Ghia AJ, Kim MM, Solanki AA, Sachdev S, Tsien C, Wang TJC, Mehta MP, McMullen KP) J Neurooncol 2019 May;143(1):157-166 PMID: 30888558 PMCID: PMC6483830 SCOPUS ID: 2-s2.0-85063194539 03/20/2019       6 Citations
  • Pretreatment Volume of MRI-Determined White Matter Injury Predicts Neurocognitive Decline After Hippocampal Avoidant Whole-Brain Radiation Therapy for Brain Metastases: Secondary Analysis of NRG Oncology Radiation Therapy Oncology Group 0933 (Bovi JA, Pugh SL, Sabsevitz D, Robinson CG, Paulson E, Mehta MP, Gondi V, Kundapur V, Shahin MS, Chao ST, Machtay M, DeNittis AS, Laack NN, Greenspoon JN, Moore KN, Huang J, Dominello MM, Kachnic LA) Advances in Radiation Oncology 2019 SCOPUS ID: 2-s2.0-85070868115 01/01/2019    
  • Prevention of Brain Metastases. (Bovi JA) Front Neurol 2018;9:758 PMID: 30323785 PMCID: PMC6172309 10/17/2018    
  • Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order. (Bovi JA, Schultz CJ, Mehta MP, Corn BW) Int J Radiat Oncol Biol Phys 2018 09 01;102(1):59-60 PMID: 30102204 SCOPUS ID: 2-s2.0-85050800872 08/14/2018    
  • Current Predictive Indices and Nomograms To Enable Personalization of Radiation Therapy for Patients With Secondary Malignant Neoplasms of the Central Nervous System: A Review. (Gilbride L, Siker M, Bovi J, Gore E, Schultz C, Hall WA) Neurosurgery 2018 05 01;82(5):595-603 PMID: 29669114 SCOPUS ID: 2-s2.0-85068839760 04/19/2018       3 Citations
  • Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. (Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby LS, Modi JM, Alleman AM, Galvin J, Brachman D, Jenrette JM, De Groot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP) J Neurosurg 2018 07;129(1):35-47 PMID: 28984517 PMCID: PMC5889346 SCOPUS ID: 2-s2.0-85041393416 10/07/2017       54 Citations
  • Dosimetric Feasibility of Preoperative Partial Breast Irradiation in Prone Position Using a Magnetic Resonance Linear Accelerator. (Prior PW Jr, Currey AD, Kelly TR, Bovi JA, Bergom C, Li A) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E691-E692 PMID: 27675373 09/28/2016    
  • Pulsed Reduced Dose Rate Reirradiation (PRDR) Using Modulated Arc (mARC) Intensity Modulated Radiation Therapy for Recurrent Gliomas: Initial Clinical Outcomes of a Novel Technique. (Siker ML, Firat S, Prah D, Schultz CJ, Dayal A, Masterson C, Connelly JM, Mueller WM, Bovi JA) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E125-E126 PMID: 27673841 09/28/2016    
  • Clinical Significance of Updated MRI Simulation Versus Immediate Postoperative MRI for Radiation Treatment Planning in Patients With Glioblastoma: Changes in FLAIR Signal. (Dayal A, Siker ML, Firat S, Bovi JA, Schultz CJ, Mueller WM, Connelly JM, Rand SD) Int J Radiat Oncol Biol Phys 2016 Oct 1;96(2S):E103 PMID: 27673785 09/28/2016    
  • Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma. (Nguyen HS, Milbach N, Hurrell SL, Cochran E, Connelly J, Bovi JA, Schultz CJ, Mueller WM, Rand SD, Schmainda KM, LaViolette PS) AJNR Am J Neuroradiol 2016 Dec;37(12):2201-2208 PMID: 27492073 PMCID: PMC5161572 SCOPUS ID: 2-s2.0-85006469905 08/06/2016       24 Citations
  • Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. (Glass J, Won M, Schultz CJ, Brat D, Bartlett NL, Suh JH, Werner-Wasik M, Fisher BJ, Liepman MK, Augspurger M, Bokstein F, Bovi JA, Solhjem MC, Mehta MP) J Clin Oncol 2016 05 10;34(14):1620-5 PMID: 27022122 PMCID: PMC4872318 SCOPUS ID: 2-s2.0-84969916579 03/30/2016       52 Citations
  • Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539. (Rogers CL, Perry A, Pugh S, Vogelbaum MA, Brachman D, McMillan W, Jenrette J, Barani I, Shrieve D, Sloan A, Bovi J, Kwok Y, Burri SH, Chao ST, Spalding AC, Anscher MS, Bloom B, Mehta M) Neuro Oncol 2016 Apr;18(4):565-74 PMID: 26493095 PMCID: PMC4799683 SCOPUS ID: 2-s2.0-84966686843 10/24/2015       35 Citations
  • Evaluation of pre-radiotherapy apparent diffusion coefficient (ADC): patterns of recurrence and survival outcomes analysis in patients treated for glioblastoma multiforme. (Elson A, Paulson E, Bovi J, Siker M, Schultz C, Laviolette PS) J Neurooncol 2015 May;123(1):179-88 PMID: 25894597 SCOPUS ID: 2-s2.0-84929836750 04/22/2015       15 Citations
  • Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. (Brachman DG, Pugh SL, Ashby LS, Thomas TA, Dunbar EM, Narayan S, Robins HI, Bovi JA, Rockhill JK, Won M, Curran WP) Int J Radiat Oncol Biol Phys 2015 Apr 01;91(5):961-7 PMID: 25832688 PMCID: PMC4706375 SCOPUS ID: 2-s2.0-84925324709 04/04/2015       13 Citations
  • Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting. (Elson A, Walker A, Bovi JA, Schultz C) Front Oncol 2015;5:27 PMID: 25709970 PMCID: PMC4321406 02/25/2015    
  • Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma. (Elson A, Bovi J, Siker M, Schultz C, Paulson E) J Neurooncol 2015 May;122(3):549-58 PMID: 25700835 SCOPUS ID: 2-s2.0-84939984579 02/24/2015       12 Citations
  • Spinal Cord Tumors (Siker ML, Bovi J, Alexander B) Clinical Radiation Oncology 1 January 2015:521-540.e5 SCOPUS ID: 2-s2.0-85072318941 01/01/2015    
  • Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade glioma. (LaViolette PS, Mickevicius NJ, Cochran EJ, Rand SD, Connelly J, Bovi JA, Malkin MG, Mueller WM, Schmainda KM) Neuro Oncol 2014 Dec;16(12):1599-606 PMID: 25059209 PMCID: PMC4232087 SCOPUS ID: 2-s2.0-84938693563 07/26/2014       34 Citations
  • Effect of treatment modality on the hypothalamic-pituitary function of patients treated with radiation therapy for pituitary adenomas: hypothalamic dose and endocrine outcomes. (Elson A, Bovi J, Kaur K, Maas D, Sinson G, Schultz C) Front Oncol 2014;4:73 PMID: 24782984 PMCID: PMC3988389 SCOPUS ID: 2-s2.0-84901047928 05/02/2014    
  • The role of pre-treatment white matter abnormalities in developing white matter changes following whole brain radiation: a volumetric study. (Sabsevitz DS, Bovi JA, Leo PD, Laviolette PS, Rand SD, Mueller WM, Schultz CJ) J Neurooncol 2013 Sep;114(3):291-7 PMID: 23813291 SCOPUS ID: 2-s2.0-84883157173 07/03/2013       5 Citations
  • Radiation therapy in the prevention of brain metastases. (Bovi JA, White J) Curr Oncol Rep 2012 Feb;14(1):55-62 PMID: 22134834 SCOPUS ID: 2-s2.0-84857638123 12/03/2011       13 Citations
  • Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss. (Wackym PA, Runge-Samuelson CL, Nash JJ, Poetker DM, Albano K, Bovi J, Michel MA, Friedland DR, Zhu YR, Hannley MT) Otol Neurotol 2010 Dec;31(9):1480-7 PMID: 20930653 SCOPUS ID: 2-s2.0-78649520552 10/12/2010       25 Citations
  • Current management of primary central nervous system lymphoma. (Schultz CJ, Bovi J) Int J Radiat Oncol Biol Phys 2010 Mar 01;76(3):666-78 PMID: 20159361 SCOPUS ID: 2-s2.0-76049085618 02/18/2010       34 Citations
  • Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. (Bovi J, Qi XS, White J, Li XA) Radiother Oncol 2007 Sep;84(3):226-32 PMID: 17692980 SCOPUS ID: 2-s2.0-34548426599 08/19/2007       42 Citations
  • Postirradiation morphea in a breast cancer patient. (Dubner S, Bovi J, White J, Susnik B) Breast J 2006 Mar-Apr;12(2):173-6 PMID: 16509846 SCOPUS ID: 2-s2.0-33645454845 03/03/2006       21 Citations
    • Last update: 09/18/2020
    jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a